Alterations in the phosphodiesterase type 5 pathway and oxidative stress correlate with erectile function in spontaneously hypertensive rats

J Cell Mol Med. 2020 Dec;24(24):14280-14292. doi: 10.1111/jcmm.16045. Epub 2020 Oct 29.

Abstract

To explore how alterations in the phosphodiesterase type 5 (PDE5) signalling pathway and oxidative stress correlate with changes in the expression of relaxation and contraction molecules and erectile dysfunction (ED) in the corpus cavernosum smooth muscle (CCSM) of spontaneously hypertensive rats (SHR). In this study, SHR and Wistar-Kyoto (WKY) rats were used. Erectile function was determined by apomorphine test and electrical stimulation (ES) of cavernous nerve. Masson's trichrome staining and confocal microscopy were performed. Nitric oxide synthase (NOS), PDE5, phosphorylated-PDE5 and α1-adrenergic receptor (α1AR) were determined by RT-PCR and Western blotting while oxidative stress in CC was determined by colorimetric analysis. SHR exhibited obvious ED. CC of SHR showed less SM but more collagen fibres. The expression of NOS isoforms in SHR was significantly decreased while all α1AR isoforms were increased. In addition, PDE5 and phosphorylated-PDE5 were down-regulated and its activity attenuated in the hypertensive rats. Meanwhile, the SHR group suffered oxidative stress, which may be modulated by endoplasmic reticulum stress and NADPH oxidase up-regulation. Dysregulation of NOS and α1AR, histological changes and oxidative stress in CC may be associated with the pathophysiology of hypertension-induced ED. In addition, PDE5 down-regulation may lead to the decreased efficacy of PDE5 inhibitors in some hypertensive ED patients and treatment of oxidative stress could be used as a new therapeutic target for this type of ED.

Keywords: corpus cavernosum; erectile dysfunction; hypertension; oxidative stress; phosphodiesterase type 5; spontaneously hypertensive rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers
  • Catalase / metabolism
  • Cyclic Nucleotide Phosphodiesterases, Type 5 / metabolism*
  • Disease Models, Animal
  • Erectile Dysfunction / drug therapy
  • Erectile Dysfunction / etiology
  • Erectile Dysfunction / metabolism
  • Fluorescent Antibody Technique
  • Humans
  • Hypertension / complications
  • Hypertension / etiology
  • Hypertension / metabolism
  • Male
  • Nitric Oxide Synthase / metabolism
  • Oxidative Stress* / drug effects
  • Penile Erection* / drug effects
  • Phosphodiesterase 5 Inhibitors / pharmacology
  • Rats
  • Reactive Oxygen Species / metabolism
  • Signal Transduction* / drug effects

Substances

  • Biomarkers
  • Phosphodiesterase 5 Inhibitors
  • Reactive Oxygen Species
  • Catalase
  • Nitric Oxide Synthase
  • Cyclic Nucleotide Phosphodiesterases, Type 5